Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vanda Pharmaceuticals

4.24
-0.0800-1.85%
Post-market: 4.240.00000.00%19:47 EDT
Volume:361.22K
Turnover:1.54M
Market Cap:249.88M
PE:-5.57
High:4.36
Open:4.30
Low:4.21
Close:4.32
Loading ...
May 05, 2021

Major Issues Report

8-K - Current report
Feb 25, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Major Issues Report

8-K - Current report
Jan 25, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 02, 2020

Major Issues Report

8-K - Current report
Oct 29, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 28, 2020

Major Issues Report

8-K - Current report
Aug 18, 2020

Major Issues Report

8-K - Current report
Aug 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2020

Major Issues Report

8-K - Current report
Jul 29, 2020

Major Issues Report

8-K - Current report
Jun 11, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jun 11, 2020

Major Issues Report

8-K - Current report